The detection of disseminated tumor cells in bone marrow and peripheral blood of gastric cancer patients by multimarker (CEA, CK20, TFF1 and MUC2) quantitative real-time PCR

Clinical Biochemistry

Volumn 44, Issue 4, 2011, Pages 325-330

  Dardaei, L ^a,b,c   Shahsavani, R ^a   Ghavamzadeh, A ^a   Behmanesh, M ^b   Aslankoohi, E ^a   Alimoghaddam, K ^a   Ghaffari, S H ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

CEA; CK20; Disseminated tumor cell; Gastric cancer; MUC2; Quantitative real time PCR; TFF1

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19; CYTOKERATIN 20; GROWTH FACTOR; MUCIN 2; TREFOIL FACTOR 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BONE MARROW EXAMINATION; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISSEMINATED CANCER; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; MALE; METASTASIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; TUMOR CELL;

BONE MARROW; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; CELL LINE, TUMOR; DNA PRIMERS; FEMALE; HUMANS; KERATIN-20; MALE; MIDDLE AGED; MUCIN-2; MULTILOCUS SEQUENCE TYPING; NEOPLASTIC CELLS, CIRCULATING; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 79651470120     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.11.005     Document Type: Article

References (39)

1. Parkin D.M. International variation. Oncogene 2004, 23:6329-6340.
2. Yaghoobi M., Bijarchi R., Narod S.A. Family history and the risk of gastric cancer. Br J Cancer 2010, 102:237-242.
3. Pituch-Noworolska A., Kolodziejczyk P., Kulig J., Drabik G., Szczepanik A., Czupryna A., et al. Circulating tumour cells and survival of patients with gastric cancer. Anticancer Res 2007, 27:635-640.
4. Kim J.P., Lee J.H., Kim S.J., Yu H.J., Yang H.K. Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer. Gastric Cancer 1998, 1:125-133.
5. Saragoni L., Gaudio M., Morgagni P., Folli S., Bazzocchi F., Scarpi E., et al. Identification of occult micrometastases in patients with early gastric cancer using anti-cytokeratin monoclonal antibodies. Oncol Rep 2000, 7:535-539.
6. Rosenberg R., Nekarda H., Bauer P., Schenck U., Hoefler H., Siewert J.R. Free peritoneal tumour cells are an independent prognostic factor in curatively resected stage IB gastric carcinoma. Br J Surg 2006, 93:325-331.
7. Weitz J., Kienle P., Magener A., Koch M., Schrodel A., Willeke F., von Knebel Doeberitz M., et al. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow. Clin Cancer Res 1999, 5:1830-1836.
8. Braun S., Hepp F., Kentenich C.R., Janni W., Pantel K., Riethmuller G., et al. Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow. Clin Cancer Res 1999, 5:3999-4004.
9. Vogel I., Kruger U., Marxsen J., Soeth E., Kalthoff H., Henne-Bruns D., et al. Disseminated tumor cells in pancreatic cancer patients detected by immunocytology: a new prognostic factor. Clin Cancer Res 1999, 5:593-599.
10. Vogel I., Kalthoff H. Disseminated tumour cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas. Virchows Arch 2001, 439:109-117.
11. Jonas S., Weinrich M., Tullius S.G., Al-Abadi H., Steinbrich R., Radke C., et al. Microscopic tumor cell dissemination in gastric cancer. Surg Today 2004, 34:101-106.
12. Braun S., Naume B. Circulating and disseminated tumor cells. J Clin Oncol 2005, 23:1623-1626.
13. Braun S., Marth C. Circulating tumor cells in metastatic breast cancer-toward individualized treatment?. N Engl J Med 2004, 351:824-826.
14. Maestro L.M., Sastre J., Rafael S.B., Veganzones S.B., Vidaurreta M., Martin M., et al. Circulating tumor cells in solid tumor in metastatic and localized stages. Anticancer Res 2009, 29:4839-4843.
15. Berois N., Varangot M., Aizen B., Estrugo R., Zarantonelli L., Fernandez P., et al. Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR. Eur J Cancer 2000, 36:717-723.
16. Ikeguchi M., Ohro S., Maeda Y., Fukuda K., Yamaguchi K., Shirai H., et al. Detection of cancer cells in the peripheral blood of gastric cancer patients. Int J Mol Med 2003, 11:217-221.
17. Xu D., Li X.F., Zheng S., Jiang W.Z. Quantitative real-time RT-PCR detection for CEA, CK20 and CK19 mRNA in peripheral blood of colorectal cancer patients. J Zhejiang Univ Sci B 2006, 7:445-451.
18. Takeuchi H., Kitagawa Y. Circulating tumor cells in gastrointestinal cancer. J Hepatobiliary Pancreat Sci 2010, 17:577-582.
19. Chen C.C., Hou M.F., Wang J.Y., et al. Simultaneous detection of multiple mRNA markers CK19, CEA, c-Met, Her2/neu and hMAM with membrane array, an innovative technique with a great potential for breast cancer diagnosis. Cancer Lett 2006, 240:279-288.
20. Gradilone A., Gazzaniga P., Silvestri I., et al. Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease. Oncol Rep 2003, 10:217-222.
21. Koike T., Shimada T., Fujii Y., et al. Up-regulation of TFF1 (pS2) expression by TNF-alpha in gastric epithelial cells. J Gastroenterol Hepatol 2007, 22:936-942.
22. Yamachika T., Werther J.L., Bodian C., Babyatsky M., Tatematsu M., Yamamura Y., et al. Intestinal trefoil factor: a factor of poor prognosis in gastric carcinoma. Clin Cancer Res 2002, 8:1092-1099.
23. Khattab AZ, Nasif WA, Lotfy M. MUC2 and MUC6 apomucins expression in human gastric neoplasm: an immunohistochemical analysis. Med Oncol in press. [Electronic publication ahead of print]. doi:10.1007/s12032-010-9699-5.
24. Xing C., Kato S., Matsukura N., Matsuda N., Xu H., Takashi E., et al. Interleukin-8, cyclo-oxygenase-2, and trefoil factor family 1 gene expression and their association with Helicobacter pylori infection in the remnant stomach. Surg Today 2005, 35:1026-1032.
25. Jono H., Shuto T., Xu H., Kai H., Lim D.J., Gum J.R., et al. Transforming growth factor-beta-Smad signaling pathway cooperates with NF-kappa B to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription. J Biol Chem 2002, 277:45547-45557.
26. Ghaffari S.H., Rostami S., Bashash D., Alimoghaddam K., Ghavamzadeh A. Real-time PCR analysis of PML-RAR alpha in newly diagnosed acute promyelocytic leukaemia patients treated with arsenic trioxide as a front-line therapy. Ann Oncol 2006, 17:1553-1559.
27. Engell H.C. Cancer cells in the circulating blood; a clinical study on the occurrence of cancer cells in the peripheral blood and in venous blood draining the tumour are at operation. Ugeskr Laeger 1995, 117:822-823.
28. Lurje G, Schiesser M, Claudius A, Schneider PM. Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications. J Oncol in press. [Electronic publication ahead of print]. doi:10.1155/2010/392652.
29. Fehm T., Sagalowsky A., Clifford E., Beitsch P., Saboorian H., Euhus D., et al. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 2002, 8:2073-2084.
30. Paterlini-Brechot P., Benali N.L. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 2007, 253:180-204.
31. Leather A.J., Gallegos N.C., Kocjan G., Savage F., Smales C.S., Hu W., et al. Detection and enumeration of circulating tumour cells in colorectal cancer. Br J Surg 1993, 80:777-780.
32. Chen Y.H., Gao W., Zhou T., Zhao W., Zhao H., Liu D., et al. Detection of bone marrow micrometastasis. Hybridoma 1999, 18:465-466.
33. Van der Auwera I., Peeters D., Benoy I.H., et al. Circulating tumour cell detection: a direct comparison between the Cell Search System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer. Br J Cancer 2010, 102:276-284.
34. Ghossein R.A., Bhattacharya S. Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours. Eur J Cancer 2000, 36:1681-1694.
35. Leteurtre E., Zerimech F., Piessen G., Wacrenier A., Leroy X., Copin M.C., et al. Relationships between mucinous gastric carcinoma, MUC2 expression and survival. World J Gastroenterol 2006, 12:3324-3331.
36. Ikeguchi M., Kaibara N. Detection of circulating cancer cells after a gastrectomy for gastric cancer. Surg Today 2005, 35:436-441.
37. de Manzoni G., Pelosi G., Pavanel F., et al. The presence of bone marrow cytokeratin-immunoreactive cells does not predict outcome in gastric cancer patients. Br J Cancer 2002, 6:1047-1051.
38. Vogelaar F.J., Mesker W.E., Rijken A.M., et al. Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study. BMC Cancer 2010, 10:153.
39. Baker M.K., Mikhitarian K., Osta W., et al. Molecular detection of breast cancer cells in the peripheral blood of advanced-stage breast cancer patients using multimarker real-time reverse transcription-polymerase chain reaction and a novel porous barrier density gradient centrifugation technology. Clin Cancer Res 2003, 9:4865-4871.